Omnicell (OMCL) Tops Q1 EPS by 15c

Omnicell (NASDAQ: OMCL) reported Q1 EPS of $0.83, $0.15 better than the analyst estimate of $0.68. Revenue for the quarter came in at $319 million versus the consensus estimate of $314.36 million.

GUIDANCE:

Omnicell sees Q2 2022 EPS of $0.82-$0.89, versus the consensus of $0.88. Omnicell sees Q2 2022 revenue of $337-343 million, versus the consensus of $337.28 million.

Omnicell sees FY2022 EPS of $3.85-$4.05, versus the consensus of $3.67. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.4 billion.

For earnings history and earnings-related data on Omnicell (OMCL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance